宏源药业：公司的磷酸西格列汀片已通过一致性评价

Core Viewpoint - Hongyuan Pharmaceutical's Dapagliflozin Tablets have passed the consistency evaluation, indicating a significant milestone for the company in the pharmaceutical industry [2] Company Summary - Hongyuan Pharmaceutical announced on October 31 that its Dapagliflozin Tablets have successfully passed the consistency evaluation, which is a crucial step for the product's market competitiveness [2]